Search research articles
Contact Us
Filters
Showing results (41-50 of 72) with videos related to
Page
of 8
Sort By:
Critical Reviews in Oncology/Hematology
|
September 10, 2011
Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questions
Peter Valent, Günther Gastl, Klaus Geissler, et al.
Wiener Klinische Wochenschrift
|
January 1, 2009
Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform
Peter Valent, Thomas Lion, Dominik Wolf, et al.
Journal of Geriatric Oncology
|
September 30, 2023
Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study
Gudrun Piringer, Josef Thaler, Sandro Anchisi, et al.
Breast Cancer Research and Treatment
|
July 29, 2008
The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer
Rupert Bartsch, Brigitte Mlineritsch, Michael Gnant, et al.
Cancer Medicine
|
November 12, 2018
Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial
Theresa Westphal, Gabriel Rinnerthaler, Simon Peter Gampenrieder, et al.
Scientific Reports
|
September 18, 2023
Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment
Bernhard Doleschal, Hossein Taghizadeh, Gerald Webersinke, et al.
Anticancer Research
|
November 5, 2014
Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trial
Wolfgang Eisterer, Alexander De Vries, Dietmar Öfner, et al.
British Journal of Cancer
|
October 21, 2016
Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer
Meinolf Karthaus, Ralf-Dieter Hofheinz, Laurent Mineur, et al.
Anticancer Research
|
January 1, 2015
Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial
Magdalena Pircher, Brigitte Mlineritsch, Michael A Fridrik, et al.
Frontiers in Oncology
|
August 25, 2023
LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases-a phase II study
Gudrun Piringer, Thomas Gruenberger, Josef Thaler, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 72) with videos related to
Sort By:
Page
of 8
Critical Reviews in Oncology/Hematology
|
September 10, 2011
Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questions
Peter Valent, Günther Gastl, Klaus Geissler, et al.
Wiener Klinische Wochenschrift
|
January 1, 2009
Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform
Peter Valent, Thomas Lion, Dominik Wolf, et al.
Journal of Geriatric Oncology
|
September 30, 2023
Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study
Gudrun Piringer, Josef Thaler, Sandro Anchisi, et al.
Breast Cancer Research and Treatment
|
July 29, 2008
The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer
Rupert Bartsch, Brigitte Mlineritsch, Michael Gnant, et al.
Cancer Medicine
|
November 12, 2018
Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial
Theresa Westphal, Gabriel Rinnerthaler, Simon Peter Gampenrieder, et al.
Scientific Reports
|
September 18, 2023
Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment
Bernhard Doleschal, Hossein Taghizadeh, Gerald Webersinke, et al.
Anticancer Research
|
November 5, 2014
Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trial
Wolfgang Eisterer, Alexander De Vries, Dietmar Öfner, et al.
British Journal of Cancer
|
October 21, 2016
Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer
Meinolf Karthaus, Ralf-Dieter Hofheinz, Laurent Mineur, et al.
Anticancer Research
|
January 1, 2015
Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial
Magdalena Pircher, Brigitte Mlineritsch, Michael A Fridrik, et al.
Frontiers in Oncology
|
August 25, 2023
LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases-a phase II study
Gudrun Piringer, Thomas Gruenberger, Josef Thaler, et al.
Page
of 8